Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 20 and 45 years old
- Women who are within 3 years of age (older or younger) of the main study participant (the "case")
- Women who have been living in the study area for the past 3 years
- Women who have had at least one menstrual period in the past 12 months
- Women who have been diagnosed with a primary breast cancer confirmed by a tissue sample test (this criterion applies only to the main study participants, called "cases")
Who may not be able to join:
- Women currently receiving cancer treatments such as radiation therapy, chemotherapy, or anti-estrogen medications (except treatment for certain common skin cancers)
- Women who are currently taking, or have taken in the past 6 months, any of the following medications: tamoxifen, raloxifene (Evista), toremifene (Fareston), exemestane (Aromasin), letrozole (Femara), anastrozole (Arimidex), or megestrol (Megace)
- Women with long-term kidney failure
- Women with a condition that would make communication during the study difficult (confirm with trial site)
- Women who are currently pregnant or breastfeeding
- Women who have previously been diagnosed with any cancer, except for certain common skin cancers
- Women excluded for any other reason determined by the trial site (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sabina Rinaldi, PhD, International Agency for Research on Cancer, Lyon, France
Phone: +33 472738485
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
breast cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.